ACE inhibitor: Clinical Trials

20 trials of ACE inhibitor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 5 unknown, 3 recruiting, 3 terminated. 10 Phase 4, 3 Not applicable, 3 Phase 3, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 410Unknown 3, Completed 2, Recruiting 2, Terminated 2, Suspended 1
Not applicable3Active not recruiting 1, Completed 1, Recruiting 1
Phase 33Completed 1, Terminated 1, Unknown 1
Phase 11Completed 1
Phase 21Completed 1

Follow ACE inhibitor: new trials by email Literature Review of ACE inhibitor trials Research Report on ACE inhibitor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk
Beta Blocker, ACE inhibitor, Calcium channel blocker - Hypertension, Fall Risk
Not applicableRecruitingAbant Izzet Baysal University1862025-08-012026-02-12
Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure
Ramipril - Chronic Kidney Disease, Heart Failure With Reduced Ejection Fraction (HFrEF)
Phase 4RecruitingEvi Liliek Wulandari802025-06-302025-12-10
STunning in Acute Myocardial Infarction - BAS
Bisoprolol Oral Tablet, Ramipril Oral Product, Dapagliflozin Oral Product - Myocardial Infarct
Phase 4RecruitingVastra Gotaland Region1202025-01-062026-10-13
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes
dapagliflozin, ACE inhibitor - Diabetic Kidney Disease, Type 1 Diabetes
Phase 4UnknownThe First Affiliated Hospital with Nanjing Medical University542024-07-012024-08-01
Replication of the PARADIGM-HF Heart Failure Trial in Healthcare Claims Data.
ACE inhibitor, Sacubitril/Valsartan - Heart Failure
CompletedBrigham and Women's Hospital60662020-09-222023-08-01
Coronavirus (COVID-19) ACEi/ARB Investigation
Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor - Hypertension, COVID-19
Phase 4SuspendedNational University of Ireland, Galway, Ireland24142020-04-302020-06-30
Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone
Sulodexide, Statin, Antiplatelet Agents - Peripheral Arterial Obstructive Disease
Phase 3UnknownAlfa Wassermann Tunisia1562019-01-312019-12-02
Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT
Beta blocker, ACEI, ARB - Myocardial Infarction With Non-obstructive Coronary Arteries
Phase 4TerminatedUppsala University1982018-12-162023-11-27
Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients
SGLT2 inhibitor, ACE inhibitor - Diabetic Nephropathies
Phase 4UnknownNahla H Tohami602018-06-202020-04-21
Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
Mycophenolate Mofetil, ACE inhibitor, Corticosteroid - IgA Nephropathy
Phase 4UnknownYonsei University1002016-06-012016-12-05
A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Nutrition, Exercise, Smoking cessation - Prostate Cancer, Cardiovascular Disease
Not applicableActive not recruitingMcMaster University50002015-10-212026-07-02
Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension
Spironolactone, Furosemide,, Amiloride - Hypertension Resistant to Conventional Therapy
Phase 4CompletedSao Jose do Rio Preto Medical School722015-09-012019-04-05
Risk Factor Control Before Orthopedic Surgery
Metoprolol, Lisinopril, Atorvastatin - Osteoarthritis, Cardiovascular Disease
Phase 4TerminatedNYU Langone Health1982014-02-012020-07-27
Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
Pioglitazone 15 mg Tablet, Isosorbide Dinitrate 10Mg Tablet, Acetylsalicylic Acid 75Mg Tablet - Adverse Effect, Atherosclerosis, Coronary
Phase 4CompletedUkrainian Medical Stomatological Academy432012-11-012022-03-10
Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril
Lisinopril, Hydrochlorothiazide - Hypertension, Grade 1, Hypertension Treatment
Not applicableCompletedScripps Translational Science Institute22010-11-012015-05-20
Paramedic Initiated Lisinopril For Acute Stroke Treatment
Lisinopril, Placebo - Stroke
Phase 1CompletedNewcastle-upon-Tyne Hospitals NHS Trust142010-10-012017-03-30
Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial
Statin, ACE inhibitor, Placebo - Type 1 Diabetes
Phase 3CompletedUniversity of Cambridge4432009-01-012018-06-28
Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease
angiotensin converting enzyme inhibitor, lisinopril - Cardiovascular Disease, Chronic Kidney Disease
Phase 2CompletedUniversity of Wisconsin, Madison432009-01-012020-10-27
PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)
Ramipril, Placebo - Type 1 Diabetes
Phase 3TerminatedNorthwestern University652008-07-012015-03-17
The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?
ACE inhibitor - Covid-19, Coronavirus, Angiotensin Converting Enzyme Inhibitors, Influenza, Electronic Health Records, Epidemiology, Comorbidity, Incidence, United Kingdom
UnknownUniversity College, London13025081998-01-012020-11-13

Conditions studied

Cardiovascular Diseases (4)  ·  Hypertension (4)  ·  Diabetes Mellitus, Type 1 (3)  ·  COVID-19 (2)  ·  Coronary Artery Disease (2)  ·  Coronavirus Infections (2)  ·  Diabetes Mellitus (2)  ·  Diabetic Nephropathies (2)  ·  Myocardial Infarction (2)  ·  Renal Insufficiency, Chronic (2)  ·  Atherosclerosis (1)  ·  Coronary Disease (1)  ·  Glomerulonephritis, IGA (1)  ·  Heart Failure (1)  ·  Hypertension Resistant to Conventional Therapy (1)

Sponsors

Abant Izzet Baysal University (1)  ·  Alfa Wassermann Tunisia (1)  ·  Brigham and Women's Hospital (1)  ·  Evi Liliek Wulandari (1)  ·  McMaster University (1)  ·  NYU Langone Health (1)  ·  Nahla H Tohami (1)  ·  National University of Ireland, Galway, Ireland (1)  ·  Newcastle-upon-Tyne Hospitals NHS Trust (1)  ·  Northwestern University (1)  ·  Sao Jose do Rio Preto Medical School (1)  ·  Scripps Translational Science Institute (1)  ·  The First Affiliated Hospital with Nanjing Medical University (1)  ·  Ukrainian Medical Stomatological Academy (1)  ·  University College, London (1)

Countries

United States (6)  ·  Australia (3)  ·  Brazil (2)  ·  Canada (2)  ·  Sweden (2)  ·  Turkey (Türkiye) (2)  ·  China (1)  ·  Colombia (1)  ·  Egypt (1)  ·  India (1)  ·  Indonesia (1)  ·  Ireland (1)  ·  Israel (1)  ·  New Zealand (1)  ·  Norway (1)

Top investigators

Alp Ozel, PT, PhD (1)  ·  Anand Dixit (1)  ·  Ann Fox (1)  ·  Arjang Djamali, MD (1)  ·  Bertil Lindahl, Prof (1)  ·  Bradley Patay, MD (1)  ·  Christopher Price (1)  ·  David B Dunger, Professor (1)  ·  Dr. Darryl Leong, MBBs,MPH,PhD,FRACP,FESC (1)  ·  Imed Frikha, MD (1)  ·  Jeffrey Berger, MD (1)  ·  John William McEvoy, MBBCh MHS (1)  ·  Juan C Yugar-Toledo, MD, PhD (1)

Results publications

PMID 12479763, PMID 15106785, PMID 18391085, PMID 20651602, PMID 21423678, PMID 21444835, PMID 21502568, PMID 21676221, PMID 22416821, PMID 22948302, PMID 24078198, PMID 25392936, PMID 28875746, PMID 29091568, PMID 29433578, PMID 32108022, PMID 32998798, PMID 33100044, PMID 33203618, PMID 33238740, PMID 34072230, PMID 34870071, PMID 35212585, PMID 38124088, PMID 38958006, PMID 39407194, PMID 40859651, PMID 42056188, PMID 42246870, PMID 42669035, PMID 42718842

NIH funding

U01DK071733 (1)